- Do you, or did you, own shares of Pacira Pharmaceuticals, Inc. (NASDAQ GS: PCRX)?
- Did you purchase your shares before April 9, 2012, or between April 9, 2012 and September 24, 2014, inclusive?
- Did you lose money in your investment in Pacira Pharmaceuticals, Inc.?
- Do you want to discuss your rights?
Please contact Rigrodsky & Long, P.A. (“R & L”) to schedule a free consultation. You may call us or fill out our contact form so that we can call at your convenience. Your consultation will not create any obligation to use our services at any time.
R & L is a national law firm with decades of combined legal experience. R & L is investigating claims brought in a securities fraud class action complaint against Pacira Pharmaceuticals, Inc. ("Pacira") concerning whether Pacira and certain of the Company’s directors and/or officers made materially false and misleading statements and failed to disclose materially adverse facts during the period April 9, 2012 and September 24, 2014 (the “Class Period”), concerning the Company’s business, operations and prospects. These misrepresentations and omissions artificially inflated the price of the Company's stock throughout the Class Period.